Ambrx Biopharma Inc. is a clinical-stage company developing engineered precision biologics using its proprietary expanded genetic code technology platform. It creates antibody-drug conjugate and immune-oncology conjugate candidates, including ARX788, ARX517, ARX305, and ARX822. Ambrx collaborates with multiple pharmaceutical companies in additional therapeutic areas, including metabolic disorders and cardiovascular disease. The company was incorporated in 2003 and is headquartered in La Jolla, CA.
What is Ambrx Biopharma's quote symbol?
What is the 52 week high and low for Ambrx Biopharma (NASDAQ: AMAM)?
How much is Ambrx Biopharma stock worth today?
How much is Ambrx Biopharma's stock price per share?
What is Ambrx Biopharma's Market Cap?